Default company panoramic image

Biosan Medical

Israeli Bioengineering start-up involved in the development of Ventritek105 - novel and unique treatment system for Stroke/SAH/ICH .

  • Stage Concept Only
  • Industry Not Set
  • Location Ilan's, Ibn Gabirol, Tel Aviv, Israel
  • Currency USD

Company Summary

Ventritek105 device intended to replace current long and very risky CSF Drainage procedure following Stroke/SAH/ICH . Standard procedure takes between 2-6 weeks to complete and is very risky due to complications such as Hydrocephalus, Vasospasm and Aseptic Meningitis associated with it. Ventritek105 will cut this procedure to 3hours – 5days, will speed up patient recovery in a safe and controled mode, while reduce medical costs dramatically.


  • Default avatar
    Ofer Taran
    CEO & Business Development

    Mr. Taran is a BsC Electrical engineer with over 20 years of experience in project management, marketing and business development and has held key positions in several High-Tech companies in South Africa, U.K., Israel and the Far East. Mr. Taran has been involved in establishing OEM deals, joint ventures and technical cooperation with large organizations.

  • Default avatar
    David Michaeli

    First inventor of the MRI machine (1969), fellow member of the Congress of Neurosurgery Society, a prominent brain researcher with over 110 inventions in Neurosurgery and a senior Neurosurgeon at Rabin Medical Centre in Israel.

  • Default avatar
    Zvi Rappaport
    Director of Regulatory & Clinical Affairs

    Prof. Rappaport is in charge of the company scientific board. Director of regulatory and clinical affairs. Prof. Rappaport is also the head of the Neurosurgical department at Rabin Medical Centre as well as a senior lecture at Tel Aviv University Medical School.